Immunomodulatory effects of alpha vs beta radiopharmaceutical therapy in murine prostate cancer.
Saved in:
| Title: | Immunomodulatory effects of alpha vs beta radiopharmaceutical therapy in murine prostate cancer. |
|---|---|
| Authors: | Ferreira CA; Departments of Radiology, Pharmacology and Toxicology and Biomedical Engineering, Michigan State University, East Lansing, MI, United States.; Department of Medical Physics, University of Wisconsin-Madison, Madison, WI, United States., Potluri HK; Department of Medicine, University of Wisconsin-Madison, Madison, WI, United States., Mahmoudian M; Department of Cell and Molecular Biology, Michigan State University, East Lansing, MI, United States., Massey CF; Departments of Medical Physics and Radiology, University of Wisconsin-Madison, Madison, WI, United States., Grudzinski JJ; Departments of Medical Physics and Radiology, University of Wisconsin-Madison, Madison, WI, United States., Carston AM; Departments of Medical Physics and Radiology, University of Wisconsin-Madison, Madison, WI, United States., Clemons NB; Departments of Medical Physics and Radiology, University of Wisconsin-Madison, Madison, WI, United States., Idrissou MB; Departments of Medical Physics and Radiology, University of Wisconsin-Madison, Madison, WI, United States., Thickens AS; Departments of Medical Physics and Radiology, University of Wisconsin-Madison, Madison, WI, United States., Rosenkrans ZT; Departments of Medical Physics and Radiology, University of Wisconsin-Madison, Madison, WI, United States., Choi C; Pharmaceutical Sciences Program, University of Wisconsin-Madison, Madison, WI, United States., Kerr CP; Department of Human Oncology, University of Wisconsin-Madison, Madison, WI, United States., Pinchuk AN; Departments of Medical Physics and Radiology, University of Wisconsin-Madison, Madison, WI, United States., Kwon O; Departments of Medical Physics and Radiology, University of Wisconsin-Madison, Madison, WI, United States., Jeffery JJ; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, United States., Bednarz BP; Departments of Medical Physics and Radiology, University of Wisconsin-Madison, Madison, WI, United States.; Pharmaceutical Sciences Program, University of Wisconsin-Madison, Madison, WI, United States., Morris ZS; Department of Human Oncology, University of Wisconsin-Madison, Madison, WI, United States.; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, United States., Weichert JP; Department of Medicine, University of Wisconsin-Madison, Madison, WI, United States.; Departments of Medical Physics and Radiology, University of Wisconsin-Madison, Madison, WI, United States.; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, United States., McNeel DG; Department of Medicine, University of Wisconsin-Madison, Madison, WI, United States.; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, United States., Hernandez R; Departments of Medical Physics and Radiology, University of Wisconsin-Madison, Madison, WI, United States.; Pharmaceutical Sciences Program, University of Wisconsin-Madison, Madison, WI, United States.; Department of Human Oncology, University of Wisconsin-Madison, Madison, WI, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2025 May 22; Vol. 16, pp. 1563387. Date of Electronic Publication: 2025 May 22 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
